Fengting Huang

901 total citations
22 papers, 600 citations indexed

About

Fengting Huang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fengting Huang has authored 22 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Fengting Huang's work include RNA modifications and cancer (6 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Fengting Huang is often cited by papers focused on RNA modifications and cancer (6 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Fengting Huang collaborates with scholars based in China, United States and Germany. Fengting Huang's co-authors include Shineng Zhang, Yanyan Zhuang, Yongxun Zhuansun, Jian Tang, Wenbo Chen, Wen‐Ying Chen, Juanfei Peng, Herui Yao, Wenjie Cheng and Stefan Herz and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Cell Death and Disease.

In The Last Decade

Fengting Huang

22 papers receiving 590 citations

Peers

Countries citing papers authored by Fengting Huang

Since Specialization

Citations

This map shows the geographic impact of Fengting Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengting Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengting Huang more than expected).

Fields of papers citing papers by Fengting Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengting Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengting Huang. The network helps show where Fengting Huang may publish in the future.

Co-authorship network of co-authors of Fengting Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Fengting Huang. A scholar is included among the top collaborators of Fengting Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengting Huang. Fengting Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessment of prognostic role of a novel 7-lncRNA signature in HCC patients 2023 ·Heliyon ·(unknown), (unknown), (unknown), (unknown), (unknown), Shineng Zhang, Fengting Huang	5
2	Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment 2023 ·Cancers ·Yanyan Zhuang, (unknown), Wa Zhong, Fengting Huang, Juanfei Peng, Shineng Zhang	5
3	METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma 2022 ·Frontiers in Cell and Developmental Biology ·Liting Lu, Dandan Zheng, (unknown), Yanyan Zhuang, Juanfei Peng, (unknown), Shineng Zhang, Fengting Huang	18
4	CircMYOF triggers progression and facilitates glycolysis via the VEGFA/PI3K/AKT axis by absorbing miR-4739 in pancreatic ductal adenocarcinoma 2021 ·Cell Death Discovery ·(unknown), (unknown), Juanfei Peng, Yanyan Zhuang, Yuanhua Li, (unknown), Shineng Zhang, Fengting Huang	15
5	Primary Esophageal Lymphoma: Clinical Experience in Diagnosis and Treatment 2021 ·Cureus ·(unknown), Yanyan Zhuang, Dandan Zheng, Fengting Huang, Shineng Zhang	1
6	MSCs exosomal miR-1470 promotes the differentiation of CD4+CD25+FOXP3+ Tregs in asthmatic patients by inducing the expression of P27KIP1 2019 ·International Immunopharmacology ·Yongxun Zhuansun, (unknown), Fengting Huang, Lin Lin, Rui Chen, Shanping Jiang, Jianguo Li	40
7	A novel long noncoding RNA OECC promotes colorectal cancer development and is negatively regulated by miR-143-3p 2018 ·Biochemical and Biophysical Research Communications ·Fengting Huang, Chuangyu Wen, Yongxun Zhuansun, Lan Huang, Wen‐Ying Chen, Xiangling Yang, Huanliang Liu	17
8	The novel long intergenic noncoding RNA UCC promotes colorectal cancer progression by sponging miR-143 2017 ·Cell Death and Disease ·Fengting Huang, Wen‐Ying Chen, (unknown), Yanyan Zhuang, (unknown), (unknown), Juanfei Peng, Zhe Zhu, (unknown), Yuanhua Li, Herui Yao, Shineng Zhang	54
9	Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis 2017 ·OncoTargets and Therapy ·Yongxun Zhuansun, Fengting Huang, Min Feng, Xinbao Zhao, Wen‐Ying Chen, Zhe Zhu, Shineng Zhang	37
10	Anti-PD-1/PD-L1 antibody versus conventional chemotherapy for previously-treated, advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials 2017 ·Journal of Thoracic Disease ·Yongxun Zhuansun, Fengting Huang, (unknown), Lin Lin, Rui Chen, Jianguo Li	14
11	Hepatic perivascular epithelioid cell neoplasm: A clinical and pathological experience in diagnosis and treatment 2017 ·Molecular and Clinical Oncology ·Wen‐Ying Chen, Yeqing Liu, Yanyan Zhuang, Juanfei Peng, Fengting Huang, Shineng Zhang	28
12	MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro 2017 ·Digestive Diseases and Sciences ·Fengting Huang, Juanfei Peng, Wenjie Cheng, Yanyan Zhuang, (unknown), (unknown), Jian Tang, Wen‐Ying Chen, Yuanhua Li, Shineng Zhang	26
13	Clinicopathological and prognostic significance of platelet count in patients with ovarian cancer 2017 ·Climacteric ·Quan Zhou, Fengting Huang, Zhiyong He, (unknown)	24
14	MiR-196a Promotes Pancreatic Cancer Progression by Targeting Nuclear Factor Kappa-B-Inhibitor Alpha 2014 ·PLoS ONE ·Fengting Huang, Jian Tang, Xiaohong Zhuang, Yanyan Zhuang, Wenjie Cheng, Wenbo Chen, Herui Yao, Shineng Zhang	90
15	Silencing of GATA6 Suppresses SW1990 Pancreatic Cancer Cell Growth In Vitro and Up-Regulates Reactive Oxygen Species 2013 ·Digestive Diseases and Sciences ·Wenbo Chen, Fengting Huang, Yanyan Zhuang, Jian Tang, Xiaohong Zhuang, Wenjie Cheng, (unknown), Shineng Zhang	11
16	Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance 2012 ·International Journal of Oncology ·Fengting Huang, Yongxun Zhuansun, Yanyan Zhuang, Shuli Wei, Jian Tang, Wenbo Chen, Shineng Zhang	77
17	Thymidylate synthase genetic polymorphisms and cancer risk: a meta-analysis of 37 case-control studies. 2012 ·PubMed ·Jian Tang, Peipei Wang, Yanyan Zhuang, Wenjie Chen, Fengting Huang, Shineng Zhang	5
18	Characterization of a Cancer Stem Cell-Like Side Population Derived from Human Pancreatic Adenocarcinoma Cells 2010 ·Tumori Journal ·Shineng Zhang, Fengting Huang, Yijun Huang, Wa Zhong, Yu Zhong	30
19	Expression profiles of miRNAs in human pancreatic cancer cell lines 2009 ·The Chinese-German Journal of Clinical Oncology ·Shineng Zhang, (unknown), Yu Zhong, Fengting Huang, Wa Zhong	1
20	Efficient plastid transformation in tobacco using the aphA-6 gene and kanamycin selection 2002 ·Molecular Genetics and Genomics ·Fengting Huang, Sebastian Klaus, Stefan Herz, Zhurong Zou, H. -U. Koop, T. J. Golds	76

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact